The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Immune Response Testing Market Projected To Reach By 2030?
The immune response testing market size has experienced rapid growth in recent years. It is anticipated to expand from $16.36 billion in 2025 to $18.09 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. The expansion observed in the historic period was primarily driven by the increasing prevalence of immune-related disorders, the wider use of antibody-based diagnostics, the expansion of clinical immunology laboratories, the growing adoption of ELISA testing methods, and increased vaccine response monitoring.
The immune response testing market size is projected to experience substantial growth in the coming years. It is expected to expand to $26.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. This anticipated growth throughout the forecast period stems from factors such as increasing demand for personalized immune profiling, a rising application of immune monitoring in oncology and vaccine development, the expansion of point-of-care immune testing, greater integration of AI in diagnostic interpretation, and a growing focus on early detection of immune dysfunction. Prominent trends for this period include the increasing adoption of multiplex immune assays, a rising use of cellular immune response analysis, the growing integration of automated testing platforms, the expansion of high-sensitivity diagnostic panels, and an enhanced focus on immune monitoring.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/immune-response-testing-global-market-report
What Key Factors Are Shaping The Immune Response Testing Market Landscape?
The increasing incidence of autoimmune conditions is anticipated to drive expansion in the immune response testing market in the future. Autoimmune conditions are characterized by the immune system erroneously attacking the body’s own healthy cells and tissues. The escalating prevalence of these diseases largely stems from greater exposure to environmental contaminants, which can impair immune function and provoke immune attacks on the body’s tissues. Immune response testing improves the management of autoimmune diseases by offering accurate insights into the body’s immune activity, facilitating early diagnosis and tailored treatment strategies. This testing aids in superior disease monitoring and contributes to better patient outcomes via targeted therapy modifications. For example, data from February 2024 by Arthritis Australia, an Australia-based non-profit, estimates that 562,378 Australians will have RA in 2025, constituting 14% of all arthritis cases for that year. By 2040, this figure is projected to increase by 33% to 748,721 people. This indicates an addition of 186,343 Australians suffering from RA compared to 2025. Consequently, the increasing prevalence of autoimmune diseases is fueling the expansion of the immune response testing market.
How Is The Immune Response Testing Market Organized By Segment Classification?
The immune response testing market covered in this report is segmented –
1) By Type Of Testing: Antibody Testing, Cytokine Testing, Cellular Testing, Complement System Testing
2) By Application: Allergy Testing, Human Immunodeficiency Virus (HIV) Disease, Cancer, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Other Applications
3) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings
Subsegments:
1) By Antibody Testing: Immunoglobulin G (IgG) Testing, Immunoglobulin A (IgA) Testing, Immunoglobulin M (IgM) Testing, Neutralizing Antibody Testing, Rapid Antibody Testing
2) By Cytokine Testing: Enzyme-Linked Immunosorbent Assay (ELISA)-Based Cytokine Assays, Multiplex Cytokine Assays, Flow Cytometry-Based Cytokine Assays, Cytometric Bead Array, Quantitative Polymerase Chain Reaction (qPCR)-Based Cytokine Analysis
3) By Cellular Testing: T-Cell Response Assays, B-Cell Response Assays, Natural Killer (NK) Cell Assays, Lymphocyte Proliferation Assays, ELISpot Assays
4) By Complement System Testing: Total Hemolytic Complement (CH50) Assay, Alternative Pathway Hemolytic Complement (AH50) Assay, Complement Component 3 And 4 (C3 And C4) Complement Testing, Mannose-Binding Lectin (MBL) Testing, Complement Activity Assays
What Market Trends Are Affecting The Immune Response Testing Market?
Key companies within the Immune Response Testing market are prioritizing the development of innovative solutions, such as immune profiling technologies, to cater to the escalating demand for advanced diagnostics in post-viral syndromes and adaptive immunity assessment. Immune profiling technologies are crafted to thoroughly analyze the immune system, evaluating both cellular and humoral responses, which delivers more in-depth understanding compared to traditional serological tests that primarily detect antibody levels. For example, in April 2024, Virax Biolabs Group Limited, a UK-based biotechnology company, unveiled its range of immune profiling solutions at ESCMID Global 2024, focusing on the evaluation of adaptive immunity in post-viral conditions. These solutions incorporate advanced assays, including multi-parametric flow cytometry and targeted biomarker panels, facilitating the precise characterization of immune cell subsets and functional responses. Their distinct features include high sensitivity, customizable panels for various post-viral syndromes, and integration with digital reporting platforms for simplified data interpretation. Applications extend from clinical research to personalized patient monitoring, offering advantages such as early detection of immune dysfunction and aiding in therapeutic decision-making.
Who Are The Industry Participants Involved In The Immune Response Testing Market?
Major companies operating in the immune response testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Quest Diagnostics Incorporated, Eurofins Scientific SE, PerkinElmer Inc., bioMérieux SA, Bruker Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., EUROIMMUN Medizinische Labor diagnostika AG, NanoString Technologies Inc., GenScript Biotech Corporation, Cell Signaling Technology Inc., Sysmex Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd., Merck KGaA
Get The Full Immune Response Testing Market Report:
https://www.thebusinessresearchcompany.com/report/immune-response-testing-global-market-report
Which Region Is The Largest In The Immune Response Testing Market?
North America was the largest region in the immune response testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immune response testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Immune Response Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/immune-response-testing-global-market-report
Browse Through More Reports Similar to the Global Immune Response Testing Market 2026, By The Business Research Company
Nanofibers Market Report 2026
https://www.thebusinessresearchcompany.com/report/nanofibers-global-market-report
Nanomaterials Market Report 2026
https://www.thebusinessresearchcompany.com/report/nanomaterials-global-market-report
Nanosilica Market Report 2026
https://www.thebusinessresearchcompany.com/report/nanosilica-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model